[HTML][HTML] Enterolactone alters FAK-Src signaling and suppresses migration and invasion of lung cancer cell lines
S Chikara, K Lindsey, P Borowicz… - … and alternative medicine, 2017 - Springer
Background Systemic toxicity of chemotherapeutic agents and the challenges associated
with targeting metastatic tumors are limiting factors for current lung cancer therapeutic …
with targeting metastatic tumors are limiting factors for current lung cancer therapeutic …
Enterolactone alters FAK-Src signaling and suppresses migration and invasion of lung cancer cell lines.
S Chikara, K Lindsey, P Borowicz… - 2017 - cabidigitallibrary.org
Background: Systemic toxicity of chemotherapeutic agents and the challenges associated
with targeting metastatic tumors are limiting factors for current lung cancer therapeutic …
with targeting metastatic tumors are limiting factors for current lung cancer therapeutic …
Enterolactone alters FAK-Src signaling and suppresses migration and invasion of lung cancer cell lines
S Chikara, K Lindsey, P Borowicz… - BMC …, 2017 - experts.nebraska.edu
Background: Systemic toxicity of chemotherapeutic agents and the challenges associated
with targeting metastatic tumors are limiting factors for current lung cancer therapeutic …
with targeting metastatic tumors are limiting factors for current lung cancer therapeutic …
Enterolactone alters FAK-Src signaling and suppresses migration and invasion of lung cancer cell lines.
S Chikara, K Lindsey, P Borowicz… - BMC …, 2017 - search.ebscohost.com
Background: Systemic toxicity of chemotherapeutic agents and the challenges associated
with targeting metastatic tumors are limiting factors for current lung cancer therapeutic …
with targeting metastatic tumors are limiting factors for current lung cancer therapeutic …
Enterolactone alters FAK-Src signaling and suppresses migration and invasion of lung cancer cell lines
S Chikara, K Lindsey, P Borowicz… - … and Alternative Medicine, 2017 - infona.pl
Background Systemic toxicity of chemotherapeutic agents and the challenges associated
with targeting metastatic tumors are limiting factors for current lung cancer therapeutic …
with targeting metastatic tumors are limiting factors for current lung cancer therapeutic …
[HTML][HTML] Enterolactone alters FAK-Src signaling and suppresses migration and invasion of lung cancer cell lines
S Chikara, K Lindsey, P Borowicz… - BMC Complementary …, 2017 - ncbi.nlm.nih.gov
Background Systemic toxicity of chemotherapeutic agents and the challenges associated
with targeting metastatic tumors are limiting factors for current lung cancer therapeutic …
with targeting metastatic tumors are limiting factors for current lung cancer therapeutic …
Enterolactone alters FAK-Src signaling and suppresses migration and invasion of lung cancer cell lines.
S Chikara, K Lindsey, P Borowicz… - BMC Complementary …, 2017 - europepmc.org
Background Systemic toxicity of chemotherapeutic agents and the challenges associated
with targeting metastatic tumors are limiting factors for current lung cancer therapeutic …
with targeting metastatic tumors are limiting factors for current lung cancer therapeutic …
[PDF][PDF] Enterolactone alters FAK-Src signaling and suppresses migration and invasion of lung cancer cell lines
S Chikara, K Lindsey, P Borowicz… - 2017 - academia.edu
Background: Systemic toxicity of chemotherapeutic agents and the challenges associated
with targeting metastatic tumors are limiting factors for current lung cancer therapeutic …
with targeting metastatic tumors are limiting factors for current lung cancer therapeutic …
[HTML][HTML] Enterolactone alters FAK-Src signaling and suppresses migration and invasion of lung cancer cell lines
S Chikara, K Lindsey… - BMC …, 2017 - bmccomplementmedtherapies …
Systemic toxicity of chemotherapeutic agents and the challenges associated with targeting
metastatic tumors are limiting factors for current lung cancer therapeutic approaches. To …
metastatic tumors are limiting factors for current lung cancer therapeutic approaches. To …
[PDF][PDF] Enterolactone alters FAK-Src signaling and suppresses migration and invasion of lung cancer cell lines
S Chikara, K Lindsey, P Borowicz… - 2017 - cyberleninka.org
Background: Systemic toxicity of chemotherapeutic agents and the challenges associated
with targeting metastatic tumors are limiting factors for current lung cancer therapeutic …
with targeting metastatic tumors are limiting factors for current lung cancer therapeutic …